Growth retardation and tumour inhibition by BRCA1

Nature Genetics

Volumn 12, Issue 3, 1996, Pages 298-302

  Holt, Jeffrey T ^a   Thompson, Marilyn E ^a   Szabo, Csilla ^b   Robiǹson Benion, Cheryl ^a   Arteaga, Carlos L ^a   King, Mary Claire ^b   Jensen, Roy A ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CANCER; CANCER SUSCEPTIBILITY; CANCER THERAPY; COLON CANCER; GENE MUTATION; GROWTH RETARDATION; LUNG CANCER; MOUSE; NONHUMAN; OVARY CANCER; PRIORITY JOURNAL;

ANIMALS; BRCA1 PROTEIN; CELL DIVISION; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC VECTORS; MAMMARY NEOPLASMS, ANIMAL; MICE; MICE, NUDE; MOLECULAR SEQUENCE DATA; MUTATION; NEOPLASM PROTEINS; OVARIAN NEOPLASMS; TRANSCRIPTION FACTORS; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0029925529     PISSN: 10614036     EISSN: None     Source Type: Journal    
DOI: 10.1038/ng0396-298     Document Type: Article

References (18)

1. Hall, J.M. et al. Linkage of early-onset breast cancer to chromosome 17q21. Science 250, 1684-1689 (1990)
2. Miki, Y. et al. A strong candidate gene for the breast and ovarian cancer susceptibility gens BRCA1. Science 266, 66-71 (1994)
3. Smith, S.A., Easton, D.F., Evans, D.G.R. & Ponder, B.A.J Allele losses in the region 17q12-q21 in familial breast and ovarian cancer non-randomly involve the wild-type chromosome. Nature Genet. 2, 128-131 (1992)
4. Cornelius, R S. et al. High allele loss rates at 17q12-q21 in breast and ovarian tumors from BRCA1-linked families The Breast Cancer Linkage Consortium Genes Chrom. Cancer 13, 203-210 (1995).
5. Futreal, P.A. et al BRCA1 mutations in primary breast and ovarian carcinomas. Science 266, 120-122 (1994).
6. Merajver, S.D. et al. Somatic mutations in the BRCA1 gene in sporadic ovarian tumours. Nature Genet. 9, 439-443 (1995).
7. Hosking, L. et al A somatic BRCA1 mutation in an ovarian tumour. Nature Genet. 9, 343-344 (1995).
8. Takahashi, H. et al. Mutation analysis of the BRCA1 gene in ovarian cancers. Cancer Res. 55, 2998-3002 (1995).
9. Thompson, M.E , Jensen, R A., Obermiller, P S., Page, D.L. & Holt, J.T. Decreased expression of BRCA1 accelerates growth and is often present during sporadic breast cancer progression Nature Genet. 9, 444-450 (1995).
10. Friedman, L.S. et al. Confirmation of BRCA1 by analysis of germline mutations linked to breast and ovarian cancer in ten families Nature Genet 8, 399-404 (1994).
11. Gayther, S.A. et al. Germline mutations of the BRCA1 gene in breast/ovarian cancer families. evidence for a genotype/phenotype correlation. Nature Genet 11, 428-433 (1995).
12. Marquis, S.T. et al. The developmental pattern of BRCA1 expression implies a role in differentiation of the breast and other tissues Nature Genet. 11, 17-26 (1995).
13. Lane, T.F. et al. Expression of BRCA1 is associated with terminal differentiation of ectodermally and mesodermally derived tissues in mice. Genes Dev. 9, 2712-2722 (1995).
14. Jensen, R.A. et al. BRCA1 is secreted and exhibits properties of a granin. Nature Genet 12, 303-308 (1996).
15. Arteaga, C.L. & Holt, J.T. Tissue-targeted c-fos retroviral vector inhibits established breast cancer xenografts in nude mice. Cancer Res. 56, 1098-1103 (1996).
16. Soule, H.D. & McGrath, C M. Estrogen responsive proliferation of clonal human breast carcinoma in athymic mice. Cancer Lett 10, 177-189 (1980).
17. Jensen, R A., Beeler, J.F., Heidaran, M A. & LaRochelle, W J. Purification and characterization of baculovirus-expressed human α and β platelet-derived growth factor receptors Biochemistry 31, 10887-10892 (1992).
18. Jensen, R.A., Page, D.L., & Holt, J.T. Identification of genes expressed in premalignant breast disease by microscopy-directed cloning. Proc. Natl. Acad Sci. USA 91, 9257-9261 (1994).